An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line

As the incidence of pancreatic ductal adenocarcinoma (PDAC) continues to grow, so does the need for new strategies for treatment. One such area being evaluated is cryoablation. While promising, studies remain limited and questions surrounding basic dosing (minimal lethal temperature) coupled with te...

Descripción completa

Detalles Bibliográficos
Autores principales: Baust, John M., Santucci, Kimberly L., Van Buskirk, Robert G., Raijman, Isaac, Fisher, William E., Baust, John G., Snyder, Kristi K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962332/
https://www.ncbi.nlm.nih.gov/pubmed/35203660
http://dx.doi.org/10.3390/biomedicines10020450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962332/
https://www.ncbi.nlm.nih.gov/pubmed/35203660
http://dx.doi.org/10.3390/biomedicines10020450

Ejemplares similares